Benzinga | Mar 31, 2021 08:03AM EDT

Amyris Announces It Has Signed And Closed Agreement With DSM Nutritional Products Ltd. For Exclusive Rights To Supply Amyris Products; Total Transaction Value Estimated At Over $500M

Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it has signed and closed an agreement with DSM Nutritional Products Ltd., a subsidiary of Royal DSM (AEX: DSM) for the exclusive rights to supply Amyris's product portfolio of flavor and fragrance (F&F) ingredients. Amyris will continue to develop, scale and manufacture future molecules with its existing partners and DSM.